

$CMPS (Compass Pathways) has been mentioned 5 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on November 4, 2025. @adamfeuerstein accounts for 3 mentions while @investmentguru_ contributed 2 mentions. The most recent discussion occurred on April 20, 2026, when the stock was included in a broader psychedelic medicines watchlist following executive action on federal review of psychedelic drugs. @adamfeuerstein's coverage focused on clinical trial results, noting that Compass's psilocybin drug showed positive efficacy in treatment-resistant depression trials while raising questions about competitive positioning.
@adamfeuerstein (Adam Feuerstein ✡️) mentions $CMPS most — 3 mentions in the past 12 months.
The earliest tracked mention of $CMPS in the Surfaced archive was on Nov 4, 2025.
2 FinTwit voices have mentioned $CMPS 5 times in the past 12 months.
$CMPS is mentioned most by Biotech voices on Surfaced.
